Trial Profile
Efficacy of switching strategies of raltegravir in patients with HIV-1 infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2015
Price :
$35
*
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 31 Mar 2015 New trial record